6 best cloud-based EDC software platforms for clinical trials in 2026

When every week of study setup translates directly into delayed data collection, stalled milestone billing, and compounding pressure on your trial timeline, the speed and flexibility of your electronic data capture (EDC) platform isn't a secondary consideration — it's central to how efficiently your team operates. Viedoc's EDC software delivers study builds typically completed in 2–4 weeks, supported by a no-code Designer your data management team can run independently, 99.99% uptime on Microsoft Azure, and a track record spanning 7,000+ completed studies across 75+ countries. This comparison evaluates six leading cloud-based EDC platforms across study build speed, no-code configuration capability, compliance credentials, and total cost of ownership.

Selecting an EDC platform today means choosing a system your team will depend on through amendments, audits, regulatory submissions, and program expansion. The platform's configurability, amendment turnaround, and support model will shape your operational throughput across every study it touches.

What makes this comparison relevant is that not all cloud-based EDC platforms are built for the same buyer. Enterprise-grade systems like Medidata Rave EDC are optimized for the demands of large pharma and complex Phase III programs, with build cycles that reflect that complexity. Growth-stage sponsors, SMID contract research organizations (CROs), and MedTech teams running Phase I and II studies need a platform that moves at the pace of their science, not their vendor's implementation queue.

Best cloud-based EDC solutions: quick comparison

These six eClinical platforms represent the most evaluated cloud-based EDC options for clinical trial teams across pharma, biotech, CROs, and MedTech, reviewed across study build speed, no-code configuration, compliance credentials, and total cost of ownership.

1. Viedoc

Viedoc's EDC software is designed for clinical trial teams that need to move fast without sacrificing compliance. Study builds are typically completed in 2–4 weeks — compared to industry benchmarks of up to 90 days for legacy enterprise platforms — with protocol amendments completed in days, not quarters. That speed is built on Viedoc Designer, a no-code study configuration interface your certified data managers can operate entirely in-house, with no vendor-side programmer required.

For teams managing concurrent study portfolios, two differentiators set Viedoc apart. Its transparent, study-based licensing includes unlimited user seats at no extra cost, removing the per-seat fee structures that penalize CROs and sponsors as their teams grow. The Viedoc Inspection Readiness Packet (VIRP) provides structured audit-readiness documentation available to every customer — a direct operational advantage when regulators come calling, particularly for EU and EMA-facing programs.

Viedoc is ISO 27001 and SOC 2 Type II certified, hosted on Microsoft Azure at 99.99% uptime, and compliant with 21 CFR Part 11, EU Annex 11, GDPR, HIPAA, and ICH GCP. The platform supports 40+ languages across 75+ countries, backed by 24/7 customer success from global offices. CROs benefit from Viedoc's tiered cro program, which provides preferred-vendor designation and certified training pathways for data management teams.

"My experience with Viedoc has been excellent. The database is very customisable and has been able to meet the needs of each of our studies. Customer Support has been excellent with quick turnarounds and response time." — Amanda M., Sr. Clinical Program Manager

Verified proof points:

• Study scale: 7,000+ studies run on Viedoc across 75+ countries
• User base: 140,000+ users globally; 30,000+ sites
• Build speed: Study builds typically completed in 2–4 weeks
• Uptime: 99.99% platform uptime; hosted on Microsoft Azure
• Language support: Available in 40+ languages
• Pricing: Unlimited user seats; no per-user fees; transparent, study-based licensing
• Compliance: 21 CFR Part 11, GDPR, EU Annex 11, HIPAA; ISO 27001 and SOC 2 Type II certified
• Inspection readiness: Viedoc Inspection Readiness Packet (VIRP) available to all customers
• Support: 24/7 support across global offices
• No-code designer: Studies configured in-house by certified data managers; no vendor-side programmer required

2. Medidata

Medidata offers Rave EDC, a cloud-based electronic data capture platform built on the Medidata Clinical Cloud. The system is designed for the data capture, management, cleaning, and reporting needs of multi-phase clinical trials, with single sign-on access across a unified suite that spans RTSM, eCOA, CTMS, and safety modules. Rave EDC supports mid-study protocol amendments without system downtime and provides real-time visibility into site and study performance through the Medidata Clinical Cloud data repository. The platform is used extensively in large pharma and global Phase III environments, where enterprise IT integration and deep cross-functional workflows are primary requirements. For smaller or early-phase programs, Medidata also offers Rave Lite, a more focused offering designed for Phase I, Phase IV, and post-market studies with an adaptable pricing structure.

3. Veeva

Veeva offers Vault CDMS, a cloud EDC and clinical data management suite that combines electronic data capture, coding, data cleaning, and reporting. Vault CDMS is part of the Veeva Vault Clinical Suite, which also includes CTMS, eTMF, and study start-up on a single cloud platform, enabling clinical data management and clinical operations to share a unified source of truth. The platform supports mid-study amendments without data migration or downtime, and is used across therapeutic areas including oncology and medical devices. As part of the Vault ecosystem, it carries Veeva's enterprise-grade security and validation infrastructure, positioning it for sponsors seeking to manage clinical data management in-house with modern cloud tooling.

4. Castor EDC

Castor EDC offers a cloud-native EDC and CDMS platform designed for clinical trial teams across pharma, biotech, CROs, and medical device companies. The platform uses a no-code and low-code eCRF builder that allows study teams to deploy studies without technical programming expertise, and supports mid-study protocol amendments without downtime. Castor integrates data from EHRs, eCRF, ePRO/eCOA, wearables, and laboratory sources via an open API, centralizing diverse data streams into a single compliant environment. The platform is validated for FDA 21 CFR Part 11, GDPR, ISO 27001, EU Annex 11, ICH E6(R3), and EU MDR 2017/745, covering both clinical trials and post-market clinical follow-up studies. Modular add-ons for ePRO, eConsent, and AI-assisted data extraction are available within the same unified platform.

5. Medrio

Medrio offers Medrio CDMS/EDC, a cloud-based clinical data management and electronic data capture platform built for sponsors, CROs, MedTech organizations, and biotech companies running trials from early feasibility through pivotal and post-marketing stages. The platform uses point-and-click configuration rather than custom coding, enabling study builds and mid-study amendments without downtime. Medrio supports online and offline data capture and includes an integrated suite covering ePRO/eCOA, eConsent, and RTSM. The system is compliant with FDA 21 CFR Part 11, ICH E6(R2), HIPAA, and GDPR, and hosted on Google Cloud Platform with multi-region data facilities in the US, EU, and China. Medrio positions itself for small and mid-sized teams that require enterprise-grade data management without the operational overhead of legacy enterprise platforms.

6. Oracle

Oracle offers Clinical One Data Collection, a cloud-based EDC and data harmonization platform built on Oracle Cloud Infrastructure (OCI). The platform goes beyond traditional EDC by enabling teams to collect data from multiple sources — including EHRs, wearables, and patient applications — and harmonize them in a single environment, using the AI-enabled Oracle Clinical Connector to support direct EHR-to-EDC data transfer. Clinical One Data Collection integrates with Oracle's randomization and trial supply management capability on the same Clinical One platform, providing a unified environment for data collection and supply management. The platform supports study builds across all phases and therapeutic areas, with mid-study changes deployable without downtime, as part of Oracle's broader life sciences cloud ecosystem for sponsors and CROs.

What to look for in cloud-based EDC solutions for clinical trials

Study build and amendment velocity

How quickly your team can go from a finalized protocol to a live, validated study database is one of the most consequential differences between EDC platforms in practice. Build timelines vary significantly: no-code platforms that empower in-house certified designers can complete builds in 2–4 weeks, while programmer-dependent platforms routinely require 60–90 days for the same starting point. Amendment turnaround matters just as much — every protocol change that requires a vendor ticket, a change control process, and a several-week queue creates direct trial timeline risk. Best-in-class platforms allow data managers to implement amendments in-house within days, without downtime and without additional vendor programming cost. If your team is managing a rolling protocol or an adaptive design, the amendment model is not a secondary feature — it's central to your trial's operational viability.

No-code configuration and in-house control

The distinction between platforms that require vendor-side programmers and platforms that enable in-house configuration is an operational and commercial one. Programmer-dependent EDC builds translate directly into higher per-study costs, longer timelines, and reduced agility when protocols evolve mid-study. A no-code or low-code configuration model shifts control to your certified data managers, reducing external dependency and enabling teams to scale study volume without proportional increases in build cost. The critical evaluation point isn't the vendor's description of their interface — it's whether your team can realistically build, amend, and manage a study without opening a development ticket. Certified designer training programs provide a structured pathway for data management teams to become fully independent in study configuration, which is worth verifying with the vendor before committing to a platform.

Compliance coverage and regulatory depth

Cloud-based EDC platforms must cover the regulatory frameworks relevant to your study geography and submission pathway. FDA 21 CFR Part 11 compliance for electronic records and signatures is the baseline for US-facing trials, but EU-facing programs additionally require EU Annex 11 and GDPR compliance, including data residency and audit trail requirements that Annex 11 explicitly addresses. HIPAA attestation is required for US studies handling protected health information. Programs running across multiple regions need a platform with verified multi-jurisdictional compliance, not just checkbox claims. Security certification level also matters: ISO 27001 and SOC 2 Type II certifications provide the third-party verification that procurement and IT teams will require during vendor assessment. A platform that can provide structured compliance documentation on demand — such as Viedoc's Viedoc Inspection Readiness Packet — reduces the time your QA team spends preparing for regulatory inspections.

Licensing model and total cost of ownership

Per-seat EDC pricing creates a cost that scales with your team size, not your study volume — a structural misalignment for CROs running concurrent studies with growing headcounts. Study-based or per-study licensing removes per-seat friction and makes total cost predictable at the time of contracting. Beyond the license structure itself, the total cost of ownership calculation must include implementation costs (does the vendor charge a setup fee for self-built studies?), amendment costs (does every protocol change require a paid change order?), and support model (does 24/7 coverage come standard, or is it an upsell?). Platforms with transparent, inclusive pricing remove the budget uncertainty that erodes sponsor and CRO relationships over multi-year programs.

Support infrastructure and escalation pathways

EDC platform support is not a commodity — it's a direct operational risk factor. A ticket-only support model means that a blocking issue at a site in a different time zone may not receive a response until the next business day, creating data quality risk and participant visit disruption. 24/7 live support from a team with direct platform expertise is meaningfully different from a tiered response model where complex issues are escalated on a deferred basis. Evaluate whether the vendor provides a named customer success manager, what the guaranteed response SLA looks like, and whether support is delivered by the same team across your global site network. For programs with sites across multiple time zones, 24/7 coverage is a selection criterion, not a nice-to-have.

How to choose the right cloud-based EDC solution for clinical trials

Step 1: Define your in-house configuration capability

Before evaluating platforms, assess whether your data management team has the bandwidth and training to build and maintain studies independently, or whether you'll rely primarily on vendor-delivered study builds. This shapes the entire evaluation: a no-code platform with a certified training pathway delivers a different return on investment for a team with three trained designers than for a team that will always require vendor build services. Map your team's actual configuration capability to the vendor's self-service model before committing to a platform type.

Step 2: Assess your study portfolio complexity

Phase I and II studies, observational studies, MedTech post-market programs, and adaptive trial designs each place different demands on an EDC platform. A Phase I CRO running eight concurrent studies needs amendment speed and concurrent study management; a sponsor running a complex adaptive oncology program needs advanced branching logic and real-time data visibility. Identify the study types that constitute 80% of your portfolio and evaluate platforms against those specific design requirements, not the most complex edge case.

Step 3: Evaluate compliance requirements by region and phase

Map your required regulatory compliance framework explicitly — FDA 21 CFR Part 11, EU Annex 11, GDPR, HIPAA, ICH GCP, and any jurisdiction-specific requirements — before engaging vendors. Request formal documentation of each compliance claim, not just a checkbox on a vendor's website. Platforms with ISO 27001 and SOC 2 Type II certifications provide auditable third-party validation; platforms that can provide pre-built inspection readiness documentation reduce your QA team's preparation burden before regulatory inspections.

Step 4: Scrutinize the true cost model

Request a total cost of ownership breakdown that covers license fees, setup and build costs for self-service and vendor-built studies, per-amendment costs, user seat structure, and support tier pricing. A licensing structure that appears cost-competitive at the study level can become significantly more expensive once amendment costs and per-seat fees are factored in over a multi-year program. Ask specifically whether unlimited user seats are included, whether there are setup fees for self-built studies, and whether 24/7 support is standard or an add-on.

Step 5: Choose a platform that scales with your program

If your study volume is growing, your EDC platform needs to grow with it without creating a proportional increase in cost or operational overhead. Viedoc's EDC software is designed for exactly this: unlimited user seats, a modular suite that adds ePRO, RTSM, eTMF, and Televisit capabilities alongside EDC, and a no-code design model that keeps study builds in your team's hands as volume scales. If you're evaluating platforms for a growing portfolio, book a demo to see how Viedoc's build model and compliance credentials map to your specific study pipeline.

Frequently asked questions

What is the best cloud-based EDC software for clinical trials?

Viedoc's EDC software is the best cloud-based EDC platform for clinical trial teams that prioritize study build speed, in-house configurability, and transparent pricing. Study builds are typically completed in 2–4 weeks, the platform supports 40+ languages across 75+ countries, and unlimited user seats are included in standard study-based licensing — no per-seat fees that scale with your team headcount. Medidata Rave EDC is the benchmark platform for large pharma and global Phase III programs, with extensive enterprise integration capabilities and a large established install base. Castor EDC is a strong alternative for teams prioritizing API-first data integration and modular functionality across EDC, ePRO, and eConsent.

What should I look for when choosing a cloud-based EDC platform?

The most important criteria are study build and amendment speed (can your team configure and modify studies in-house without a vendor programming queue?), regulatory compliance coverage across your trial's jurisdictions (21 CFR Part 11, EU Annex 11, GDPR, HIPAA, ISO 27001), licensing transparency (per-seat vs. per-study; what's included in the base license?), and support infrastructure (24/7 live support, or ticket-only?). Beyond these, the platform's scalability across your study portfolio — whether it handles concurrent study management, growing team sizes, and multi-module expansion without proportional cost increases — is the criterion that separates platforms for growing programs from platforms optimized for single-study use.

How long does it take to build and deploy a study on a cloud-based EDC platform?

This varies significantly by platform and configuration model. No-code platforms with in-house certified designers, such as Viedoc, typically deliver study builds in 2–4 weeks from protocol to go-live. Legacy enterprise platforms with programmer-dependent configuration models can take 60–90 days for the same process. Amendment turnaround also varies: no-code platforms allow in-house amendment deployment within days, while programmer-dependent platforms require vendor involvement for every change. For CROs and sponsors running concurrent studies, build and amendment speed compounds across the portfolio — a platform that is 10 weeks slower per study translates into months of aggregate delay across an active program.

What compliance certifications should I look for in a cloud-based EDC platform?

For US-facing trials, FDA 21 CFR Part 11 compliance is the baseline requirement for electronic records and signatures. EU-facing programs additionally require EU Annex 11 and GDPR compliance. Programs handling US protected health information require HIPAA attestation. Security credentials to verify during vendor assessment include ISO 27001 (information security management) and SOC 2 Type II (security, availability, and confidentiality controls) — both of which require independent third-party audits and carry more evidentiary weight than self-attested compliance claims. For multi-regional programs, verify that each compliance certification covers the data hosting environment and all relevant jurisdictions, not just the vendor's primary market.

What is a Viedoc Inspection Readiness Packet (VIRP)?

A Viedoc Inspection Readiness Packet (VIRP) is a structured set of audit-readiness documentation provided to all Viedoc customers, designed to support computer system validation (CSV) and prepare study teams for regulatory inspections by the FDA, EMA, or other health authorities. The VIRP compiles the documentation that regulators expect to review — system validation evidence, audit trail exports, configuration records, and supporting compliance materials — into a structured, inspection-ready format. Having pre-compiled inspection documentation reduces the time and resource burden on QA teams when an inspection is scheduled, and demonstrates proactive compliance governance to regulators. More detail is available at the Viedoc Inspection Readiness Packet guide page.

How does per-study EDC licensing differ from per-seat licensing?

Per-seat EDC licensing charges based on the number of users accessing the platform, which means licensing costs scale with team size regardless of how many studies are active. For CROs running concurrent studies with growing data management teams, per-seat pricing can create unpredictable cost escalation as headcount increases. Per-study licensing is structured around the studies your team runs rather than the size of the team running them. Viedoc's licensing model includes unlimited user seats within a per-study structure, which means adding team members, site users, or monitor access to an active study doesn't generate incremental license costs. When evaluating total cost of ownership, it's important to understand not just the per-study rate but whether user seats, amendments, and support are included or separately billed.

Making the right cloud-based EDC choice for clinical trials

Cloud-based EDC has become the standard infrastructure for clinical data collection across pharma, biotech, CROs, and MedTech, and the market now reflects a broad range of platform approaches. The platforms reviewed here span no-code, self-service models built for teams that want in-house control, to enterprise suite platforms built for integrated multi-functional workflows at scale. The global eClinical software market is estimated at over $11 billion in 2025 and growing at approximately 14% annually, which means the platform landscape will continue to evolve — but the core evaluation criteria remain stable.

The decision variables that matter most at platform selection are study volume and concurrency, team configuration capability, required compliance jurisdictions, budget model preferences, and geography. US-facing teams typically prioritize speed and return on investment; EMEA and APAC programs place greater emphasis on certification depth, multi-jurisdictional compliance, and vendor stability. What matters is applying the framework that matches your program's actual operational profile.

The switching cost of an EDC platform is material. Re-validation, site retraining, data migration, and the operational disruption of transitioning an active portfolio to a new platform are all real costs that accrue when a platform isn't the right fit from the start. Choosing carefully at the outset — with compliance requirements verified, total cost of ownership modeled, and build speed tested against your actual protocol complexity — is worth the additional evaluation effort upfront.

Why Viedoc is the best cloud-based EDC choice for clinical trials

Viedoc is built for clinical trial teams that need genuine speed, in-house control, and compliance depth without enterprise-grade overhead. Study builds typically completed in 2–4 weeks, a no-code Designer that puts study configuration in the hands of your certified data management team, and unlimited user seats on a transparent, study-based license — these are operational characteristics that translate directly to faster go-live dates, lower amendment costs, and predictable total cost of ownership across your portfolio.

The compliance credentials are comprehensive: ISO 27001 and SOC 2 Type II certified, 21 CFR Part 11, EU Annex 11, GDPR, and HIPAA compliant, hosted on Microsoft Azure at 99.99% uptime, with the Viedoc Inspection Readiness Packet available to every customer as standard. Those credentials cover the regulatory jurisdictions your studies are most likely to span, and the VIRP means your QA team spends less time assembling audit evidence when inspections are scheduled.

Viedoc has been deployed in 7,000+ studies across 75+ countries since 2003, with 140,000+ users on the platform globally. That track record matters when your sponsor, your regulator, or your QA director asks about the platform's production history. Combined with 24/7 customer success from global offices and a tiered CRO partner network, Viedoc is a platform your team can rely on across the full lifecycle of a study.

If you're evaluating cloud-based EDC options for your next study or portfolio program, book a demo or request a proposal and we'll walk you through study build speed, compliance credentials, and module depth in the context of your specific trial portfolio.